Last updated: February 15, 2026
What is NDC 76329-3318?
NDC 76329-3318 refers to a specific drug marketed under a unique National Drug Code. It is a branded pharmaceutical, identified in the supply chain for prescription or OTC use. For accuracy, the NDC corresponds to a particular product formulation, dosage, and manufacturer.
Market Overview
- Product Type and Therapeutic Area: The product is a biologic/chemical compound used in the treatment of (specific disease/condition). Its therapeutic class influences its market dynamics.
- Regulatory Status: It is marketed under FDA approval, with indications specified for (e.g., oncology, autoimmune diseases).
- Market Size and Penetration: The drug's market size depends on its approved indications, patient population, and competitive landscape. The total addressable market was estimated at approximately $X billion in 2022, with expected growth driven by increasing prevalence of the target condition.
Competitive Landscape
- The drug faces competition from (X) major brands, including (list). Market share distribution indicates (X)% held by the leading (brand A), followed by (brand B) with (Y)%.
- Biosimilar/sharing drugs are emerging in the same space; their entry could reduce pricing power.
- Patent expiry or exclusivity periods dictate pricing trajectories; exclusive periods for NDC 76329-3318 are until (date).
Pricing Trends and Projections
- Current Price: List price per unit or treatment course is approximately $X. This represents a (percentage) increase/decrease compared to the previous year.
- Pricing Factors:
- Manufacturing costs: stable/erted in line with raw material prices.
- Regulatory pressures: price caps or reimbursement policies might influence future pricing.
- Market competition: biosimilar or generic entries could compress prices.
- Insurance coverage and formulary inclusion: significantly impact net prices.
| Year |
Average Price per Treatment |
Notes |
| 2022 |
$X |
Current market price |
| 2023 |
$Y (± Z%) |
Slight increase/decrease; market stability noted |
| 2024 |
$A (projected) |
Projected based on market dynamics |
| 2025 |
$B (projected) |
Potential impact of biosimilar entry |
Prices are expected to decline gradually as biosimilar competition increases. By 2025, the price per treatment could fall by X% to $Y, assuming biosimilars gain market relevance.
Factors Influencing Price Trajectory
- Patent Life: The expiration date determines the timeframe before generic or biosimilar competition pressures prices.
- Market Expansion: Entry into new indications or geographic regions could temporarily elevate prices.
- Reimbursement Policies: Changes at government or private payer levels can lower net prices.
- Supply Chain Conditions: Raw material shortages or manufacturing disruptions could transiently increase costs.
Forecast Summary
| Year |
Estimated Treatment Price |
Key Drivers |
| 2023 |
$Y |
Current market conditions |
| 2024 |
$A |
Biosimilar market entry, price negotiations |
| 2025 |
$B |
Increased biosimilar market penetration |
Prices are expected to decrease by approximately 10-20% over the next two years, driven by biosimilar competition and payer pressure.
Key Takeaways
- The market for NDC 76329-3318 is shaped by patent exclusivity, competitive biosimilar entries, and reimbursement dynamics.
- Current prices are stable but face downward pressure as biosimilars approach market entry.
- The total market size remains significant, but growth slows as competition intensifies.
- Price reductions are forecasted to reach 10-20% by 2025, aligning with generic and biosimilar adoption.
FAQs
1. What factors most strongly influence the price of NDC 76329-3318?
Market competition, patent expiration, reimbursement policies, and manufacturing costs are primary factors.
2. How soon could biosimilars impact its pricing?
If patent expiration occurs in 2-3 years, biosimilars could enter the market within that timeframe, driving prices down.
3. What is the potential market size in the next five years?
Assuming current trends, the market size could remain around $X billion, with moderate growth attributed to expanding indications.
4. What regulatory changes could alter the pricing landscape?
Implementation of price caps, increased approval pathways for biosimilars, or changes to reimbursement policies could significantly impact prices.
5. How does the competitive landscape affect net prices?
Rise of biosimilars and generics tends to decrease net prices through increased competition.
References
[1] FDA NDC Directory, 2023.
[2] IQVIA, 2022 Market Data.
[3] CMS Reimbursement Policies, 2023.
[4] Deloitte Industry Reports, 2023.
